Showing results (161-170 of 240) with videos related to
Sort By:
Pageof 24
Ophthalmology|October 1, 1989
Endoretinal biopsy in immunosuppressed and healthy patients with retinitis. Indications, utility, and techniquesW R Freeman, C A Wiley, J G Gross, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 1, 1995
AIDS-related optic neuropathy: a histological, virological and ultrastructural studyA A Sadun, J S Pepose, M C Madigan, et al.American Journal of Ophthalmology|December 15, 1993
Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitisW R Freeman, D N Friedberg, C Berry, et al.Retina (Philadelphia, Pa.)|January 1, 1990
Pathologic observations made by retinal biopsyW R Freeman, W H Stern, J G Gross, et al.American Journal of Ophthalmology|December 15, 1990
Experimental endoretinal biopsyJ G Gross, T E Schneiderman, C A Wiley, et al.American Journal of Ophthalmology|June 1, 1996
Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study GroupJ W Kim, W R Freeman, S P Azen, et al.The British Journal of Ophthalmology|April 29, 2008
Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicleL Cheng, E Anglin, F Cunin, et al.The Journal of Infectious Diseases|July 1, 1997
High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genesI L Smith, J M Cherrington, R E Jiles, et al.The Journal of Infectious Diseases|May 21, 1998
Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapyJ C Macdonald, F J Torriani, L S Morse, et al.Ophthalmology|December 1, 1995
Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes. Results from a prospective randomized clinical trial. Vitrectomy for Macular Hole Study GroupJ W Kim, W R Freeman, W el-Haig, et al.Pageof 24